Short Interest in Click Holdings Limited (NASDAQ:CLIK) Grows By 37.8%

Click Holdings Limited (NASDAQ:CLIK) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 3,083 shares, an increase of 37.8% from the January 29th total of 2,237 shares. Based on an average daily volume of 7,217 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.3% of the company’s stock are short sold. Currently, 0.3% of the company’s stock are short sold. Based on an average daily volume of 7,217 shares, the days-to-cover ratio is presently 0.4 days.

Click Stock Down 7.8%

Shares of NASDAQ:CLIK traded down $0.30 during mid-day trading on Monday, reaching $3.54. 4,099 shares of the stock were exchanged, compared to its average volume of 9,293. The stock’s 50 day simple moving average is $4.52 and its 200-day simple moving average is $6.73. Click has a one year low of $3.01 and a one year high of $102.90.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.